Site notifications

Sub menu

 
 

Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2020 - Jun 2021

Published

The Department of Health, of which the TGA is a part, is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to disclose access decisions through a disclosure log on its website. The disclosure log provides access to information which has been released in response to an FOI request. However, personal information and information about the business, commercial, financial or professional affairs of a person is deleted from the documents if publication of that information would be unreasonable.

The documents released by the TGA under section 11C of the FOI Act have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Coordinator by emailing tga.foi@health.gov.au or calling the TGA on 1800 020 653 or 02 6289 4630.

For documents released under the FOI Act by the Department of Health, please visit the Department of Health's FOI disclosure log.

Date of releaseFOI numberDocuments
17 June 2021FOI 2183

Clinical trial results relating to the Pfizer and AstraZeneca COVID-19 vaccines

2 June 2021FOI 2289

Safety data relating to the Pfizer COVID-19 vaccine including pregnancy categorisation

28 May 2021FOI 2260

Minutes from the Meeting of the Advisory Committee on Medicines Scheduling concerning the interim decision of 3 February 2021 on the amendment of the current Poisons Standard in relation to psilocybin and MDMA.

18 May 2021FOI 2370

Request for documents relating to SAS category B applications during the period of 01/01/2019 to 30/04/2021 inclusive for medicinal cannabis

14 April 2021FOI 2250

Request for documents relating to SAS B approvals for medicinal cannabis product

1 April 2021FOI 2275

Special Access Scheme Category B pathway specific to medicinal cannabis products during the period 1/11/2016 to 1/03/2020

25 March 2021FOI 2199

Request for public ARTG summary document for therapeutic goods containing or consisting of Sitagliptin.

26 February 2021FOI 2189

Internal TGA policies and procedures relating to TGA complaint handling processes.

11 February 2021FOI 2184

Request for spreadsheet of Special Access Scheme applications for medical cannabis for period 1 August 2020 to 16 January 2021

4 February 2021FOI 2075

Documents showing the dates of approval of new indications for Risperdal (Risperidone) film coated tablets.

27 January 2021FOI 2191

The sponsor of the Birmingham Hip Resurfacing Device

25 January 2021FOI 2076

Request for documents relating to shortages of anti-seizure medications (list provided) from the TGA's Medicine Shortages Information Initiative

3 December 2020FOI 2014

Country of Origin where Paraosteo 665 is made.

3 December 2020FOI 2066

Request for documents relating to Ostelin Specialist Range Vitamin D 7000IU

25 November 2020FOI 1986

Approved use of Ethicon UltraPro Hernia Mesh

16 November 2020FOI 1866

Request for documents relating to the LARS ligament for anterior cruciate ligament injuries

12 November 2020FOI 1807

Request for documents relating to the decision made in December 2016 to up-schedule codeine

9 November 2020FOI 1985

Medicinal cannabis advertising compliance complaints

2 November 2020FOI 2013

SAS Category B applications for medicinal cannabis - 1/11/16-30/09/20

2 November 2020FOI 1871

TGA position on hydroxychloroquine

29 September 2020FOI 959

Request for details of approvals to supply Thrombin under the Special Access Scheme between January 2019 to December 2019

1 September 2020FOI 1845

Request for documents relating to Authorised Prescribers of medicinal cannabis

21 August 2020FOI 1785

Advisory Committee on Vaccines - Members Declarations of Interest

7 August 2020FOI 1814

Request for a copy of the evaluation Report for POLYGLYCERYL-6 POLYRICINOLEATE

27 July 2020FOI 1802

Request for copies of the two earliest Special Access Application forms for specified dates for the use of Humira adalimumab for the treatment of patients with inflammatory bowel disease and their approvals

23 July 2020FOI 1789

Request for copies of the two earliest Special Access Application forms for various date ranges for the use of Humira adalimumab for treating patients with psoriatic arthritis

22 July 2020FOI 1782

Request for Special Access Scheme notifications/ approvals for adalimumab (Humira) between 2002-2006

21 July 2020FOI 1741

Request for documents relating to adverse event reports for medicinal cannabis products

17 July 2020FOI 1799

Request for details about medicinal cannabis applications through SAS from 1 December 2019 - 24 June 2020

1 Jul 2019 to 30 Jun 2020Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2019 to Jun 2020
1 Jul 2018 to 30 Jun 2019Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 to Jun 2019
1 Jul 2017 to 30 Jun 2018Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018
1 Jul 2016 to 30 Jun 2017Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017
1 Jul 2015 to 30 Jun 2016Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016
1 Jul 2014 to 30 Jun 2015Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015
1 Jul 2013 to 30 Jun 2014Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014
1 Jul 2012 to 30 Jun 2013Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013
1 Jul 2011 to 30 Jun 2012Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012

Help us improve the Therapeutic Goods Administration site